Literature DB >> 9497338

Biochemical analysis of potential sites for protein 4.1-mediated anchoring of the spectrin-actin skeleton to the erythrocyte membrane.

R F Workman1, P S Low.   

Abstract

Erythrocyte protein 4.1 has been hypothesized to link the spectrin-actin junctional complex directly to the cytoplasmic domain of glycophorin C, but this bridging function has never been directly demonstrated. Because an alternative protein-mediated bridge between the junctional complex and the cytoplasmic domain of band 3 is also plausible, we have undertaken to characterize the membrane sites to which protein 4.1 can anchor the spectrin and actin skeleton. We demonstrate that proteolytic removal of the cytoplasmic domain of band 3 has minimal effect on the ability of protein 4.1 to promote 125I-labeled spectrin and actin binding to KI-stripped erythrocyte membrane vesicles. We also show that quantitative blockade of all band 3 sites with either monoclonal or polyclonal antibodies to band 3 is equally ineffective in preventing protein 4.1-mediated association of spectrin and actin with the membrane. In contrast, obstruction of protein 4.1 binding to its docking site on the cytoplasmic pole of glycophorin C is demonstrated to reduce the same protein 4.1 bridging function by approximately 85%. We conclude from these data that (i) glycophorin C contributes the primary anchoring site of the protein 4.1-mediated bridge to the spectrin-actin skeleton; (ii) band 3 is incapable of serving the same function; and (iii) additional minor protein 4.1 bridging sites may exist on the human erythrocyte membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497338     DOI: 10.1074/jbc.273.11.6171

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.

Authors:  R Bhattacharyya; A K Das; P K Moitra; B Pal; I Mandal; J Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

2.  Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant.

Authors:  Gerhard Rank; Rosemary Sutton; Vikki Marshall; Rachel J Lundie; Jacinta Caddy; Tony Romeo; Kate Fernandez; Matthew P McCormack; Brian M Cooke; Simon J Foote; Brendan S Crabb; David J Curtis; Douglas J Hilton; Benjamin T Kile; Stephen M Jane
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

3.  Protein 4.2 binds to the carboxyl-terminal EF-hands of erythroid alpha-spectrin in a calcium- and calmodulin-dependent manner.

Authors:  Catherine Korsgren; Luanne L Peters; Samuel E Lux
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

4.  Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane.

Authors:  Jesse L Grey; Gayani C Kodippili; Katya Simon; Philip S Low
Journal:  Biochemistry       Date:  2012-08-14       Impact factor: 3.162

Review 5.  A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.

Authors:  Karrie Mei-Yee Kiang; Gilberto Ka-Kit Leung
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.